$OKLO

Cochran Caroline sold $1.7M of OKLO

Cochran Caroline (Co-Founder, COO) sold 40,000 shares of Oklo Inc. (OKLO) at $41.35 ($1.65M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cochran Caroline
Published Aug 5, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

This disclosure updates the record of insider activity but does not introduce new guidance, contracts, regulatory actions, or operational changes.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no fundamental catalyst in the text.

03

What to watch

The filing does not state the insider’s tax or liquidity needs, and 10b5-1 sales can be mechanically scheduled regardless of near-term outlook.

Relevance 5/10Novelty 3/10Timing: filed Aug 5, transaction dated Aug 3 (after-hours disclosure window)

Background

The article is an SEC Form 4 insider transaction for Oklo Inc., reported by a co-founder/COO who is also a director and 10% owner.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

Oklo co-founder and COO Cochran Caroline sold 40,000 shares at $41.35 on an open-market sale under a 10b5-1 plan, per Form 4.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and outweighed by the 10b5-1 context.

Evidence & confidence

Form 4 insider sales under a pre-arranged 10b5-1 plan are typically interpreted as liquidity/plan execution rather than a fresh negative signal, and the article provides no new company fundamentals.

Market effects

No clear sector read-through from a single 10b5-1 insider sale disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be read as reduced conviction, especially if paired with other negative signals not present here.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale disclosure.

  • Cochran Caroline

    Oklo co-founder, COO, director, and 10% owner who sold shares under a 10b5-1 plan.

Related articles

$OKLOMed

Oklo’s Groves Research Reactor Achieves First Criticality

Oklo (NYSE: OKLO) said its Groves Isotope Test Reactor reached first criticality on private land, supported by DOE Reactor Pilot Program authorization. Los Alamos’ ZiaCore microreactor also achieved zero-power criticality. ARC Clean Technology (ARC) outlined plans for ARC-100 at INL and a term sheet for Turkey. Holtec, Entergy and Hyundai will evaluate SMR-300 projects in Gulf states.

$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.